Torii Pharmaceutical Co., Ltd. (TYO:4551)

Torii Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	6,725	5,593	5,722	4,767	4,225
Depreciation & Amortization	408	459	454	413	582
Loss (Gain) From Sale of Assets	200	36	1	37	9
Other Operating Activities	-1,618	-1,742	-1,987	59	-9,875
Change in Accounts Receivable	-2,565	-5,638	-854	-3,052	6,193
Change in Inventory	-3,475	-1,772	-206	-1,610	360
Change in Accounts Payable	3,719	157	264	1,168	-4,415
Change in Other Net Operating Assets	245	-216	-974	-1,938	-522
Operating Cash Flow	3,639	-3,123	2,420	-156	-3,443
Capital Expenditures	-152	-162	-120	-150	-293
Sale (Purchase) of Intangibles	-28	-54	-161	-224	-118
Investment in Securities	-1,572	-3,562	-13,781	-696	6,938
Other Investing Activities	-1,819	-1	386	-428	1,098
Investing Cash Flow	-3,571	-3,779	-13,676	-1,498	7,625
Issuance of Common Stock	-	-	-	-	8
Repurchase of Common Stock	-2	-	-	-	-
Dividends Paid	-3,654	-3,540	-1,348	-1,348	-1,347
Other Financing Activities	-288	-295	-350	-198	-86
Financing Cash Flow	-3,944	-3,835	-1,698	-1,546	-1,425
Miscellaneous Cash Flow Adjustments	-	-1	-	-1	-1
Net Cash Flow	-3,876	-10,738	-12,954	-3,201	2,756
Free Cash Flow	3,487	-3,285	2,300	-306	-3,736
Free Cash Flow Margin	5.77%	-6.01%	4.70%	-0.65%	-8.96%
Free Cash Flow Per Share	124.05	-116.89	81.86	-10.89	-133.04
Cash Income Tax Paid	1,695	1,803	2,006	-21	9,410
Levered Free Cash Flow	3,003	-8,717	3,439	652	-5,689
Unlevered Free Cash Flow	3,003	-8,717	3,439	652	-5,689
Change in Net Working Capital	1,474	12,107	197	2,297	8,822

Source: S&P Global Market Intelligence. Standard template. Financial Sources.